Skip to content
Home
Team
Healthcare
Patient-First Statement
Pipeline
Invest
Investor Hub
Corporate Governance
Shareholder Communications
News
Contact
Menu
Home
Team
Healthcare
Patient-First Statement
Pipeline
Invest
Investor Hub
Corporate Governance
Shareholder Communications
News
Contact
News
Search
Search
ASX News
General News
Publications
Thought Leadership
Uncategorised
All
August 18, 2022
Emyria’s Ultra – Pure CBD is a Step Closer to Registration
August 17, 2022
Ethics Approval for EMD-RX5 – Clinical Trials Next
August 15, 2022
Forrest’s Tenmile – Highlights Investment in Emyria
August 9, 2022
Step forward in the push for evidence-based CBD treatments
July 12, 2022
Recent EFSA Decision Highlights Real World Data’s Importance
July 7, 2022
How Can Remote Monitoring Improve Our Healthcare System?
June 8, 2022
Promising EMD-RX5 Phase One Clinical Trial results unpacked
June 2, 2022
Investor Webinar | Drug Development
May 31, 2022
Emyria expands MDMA analogue program with UWA
Load More